STOCK TITAN

Zimmer Biomet Holdings Inc - ZBH STOCK NEWS

Welcome to our dedicated news page for Zimmer Biomet Holdings (Ticker: ZBH), a resource for investors and traders seeking the latest updates and insights on Zimmer Biomet Holdings.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Zimmer Biomet Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Zimmer Biomet Holdings's position in the market.

Rhea-AI Summary
Zimmer Biomet partners with top pickleball organizations in the US to promote joint health and movement, targeting the 48.3 million players and fans. The company aims to be a trusted partner for joint replacement, focusing on the older demographic in the sport.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.88%
Tags
none
-
Rhea-AI Summary
Zimmer Biomet Holdings, Inc. (ZBH) will webcast its first quarter earnings conference call on May 2, 2024. The quarterly results will be released at 6:30 a.m. ET, with the webcast at 8:30 a.m. ET. Investors can access the live audio webcast on Zimmer Biomet's Investor Relations website. Dial-in options are available for U.S., Canada, and international participants.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.2%
Tags
-
Rhea-AI Summary
Zimmer Biomet Holdings, Inc. announces FDA clearance for ROSA® Shoulder System, the world's first robotic surgery system for shoulder replacement. The system aims to improve surgical accuracy and efficiency, offering flexibility in total shoulder replacement techniques. ROSA Shoulder integrates with Signature™ ONE Surgical Planning System 2.0 for personalized surgical planning and real-time intra-operative data to reduce complications. Commercial availability in the U.S. is expected in the second half of 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.15%
Tags
Rhea-AI Summary
Zimmer Biomet Holdings, Inc. (ZBH) declares a quarterly cash dividend of $0.24 per share for the first quarter of 2024, approved by the Board of Directors. This move reflects the company's commitment to rewarding its stockholders and maintaining financial stability.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.7%
Tags
dividends
-
Rhea-AI Summary
Zimmer Biomet Holdings, Inc. signs the Zero Health Gaps Pledge to address health disparities by integrating health equity into its core strategies. The newly established Health Equity division focuses on reducing healthcare inequities, tracking progress, and collaborating on community-based solutions. The division aims to increase patient access to quality care in underserved communities through a Community Centered Care framework and partnerships with healthcare institutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.48%
Tags
none
-
Rhea-AI Summary
Zimmer Biomet showcases innovative products at AAOS meeting, featuring ROSA Robotics for pending 510(k) clearance, Persona OsseoTi Keel Tibia, and HAMMR Automatic Hip Impaction System. The company highlights its commitment to transformative clinical care and customer-centric solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.48%
Tags
none
Rhea-AI Summary
Zimmer Biomet Holdings, Inc. reported a 6.3% increase in net sales for the fourth quarter and a 6.5% increase for the full year. Full-year diluted earnings per share were $4.88, and adjusted diluted earnings per share were $7.55. The company provided full-year 2024 financial guidance with projected revenue change of 4.5% - 5.5% and adjusted diluted EPS of $8.00 - $8.15.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.54%
Tags
-
Rhea-AI Summary
Zimmer Biomet Holdings, Inc. (ZBH) has announced its fourth quarter earnings conference call and webcast on February 8, 2024. The live audio webcast will be accessible via the company's Investor Relations website. Additionally, an in-person product showcase event for investors and analysts will be held on February 13, 2024, at the American Academy of Orthopaedic Surgeons Conference in San Francisco.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.35%
Tags
-
Rhea-AI Summary
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) appoints Louis A. Shapiro, former President and CEO of Hospital for Special Surgery, to the Board, leveraging his extensive industry leadership experience and customer perspective.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.18%
Tags
management
Rhea-AI Summary
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) to present at 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.98%
Tags
conferences
Zimmer Biomet Holdings Inc

NYSE:ZBH

ZBH Rankings

ZBH Stock Data

26.20B
204.56M
0.13%
90.99%
2.3%
Electromedical and Electrotherapeutic Apparatus Manufacturing
Manufacturing
Link
US
Warsaw

About ZBH

zimmer biomet is the world’s most trusted brand for personalized bone and joint healthcare solutions. we help people discover and achieve exceptional outcomes. as a leading innovator in musculoskeletal healthcare, we offer a complete portfolio of products for joint reconstruction, bone and skeletal repair, sports medicine, spine, and dental reconstruction. every day, we focus on improving musculoskeletal healthcare. it’s all we do. it’s all we’ve ever done. for nearly 90 years, zimmer biomet has helped people progress beyond their pain and limitations. because it’s not just what we make, it’s what we make possible. zimmer biomet serves healthcare professionals and their patients globally. our worldwide headquarters is in warsaw, indiana, usa.